Reed-Lane, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 359 Newark Pompton Turnpike, Wayne, New Jersey (NJ) 07470, United States (USA)
- Operations here
- labelpackrelabelrepack
- FDA identifiers
- FEI 3002772224 · DUNS 001819879
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2025-10-17
- VAIDrug Quality Assurance2023-03-03
- NAIDrug Quality Assurance2018-07-25
- NAIDrug Quality Assurance2016-04-26
- NAIDrug Quality Assurance2013-05-13
- NAIDrug Quality Assurance2011-05-11
- NAIDrug Quality Assurance2010-11-30
Drugs this plant is listed as making
9 distinct drugs across 24 products name this site in their FDA label.
- BUPROPION HCl ERLifestar Pharma LLC
- Bupropion HydrochlorideAmneal Pharmaceuticals of New York LLC
- Carbidopa and LevodopaAmneal Pharmaceuticals LLC
- DigoxinAmneal Pharmaceuticals of New York LLC
- FenofibrateAmneal Pharmaceuticals of New York LLC
- glyburideTEVA Pharmaceuticals USA Inc
- IsotretinoinJG Pharma Inc.
- Sevelamer CarbonateGenzyme Corporation
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.